
Transplant Hepatologist, Health Economist @UCalgaryMed. | TxHep @MayoClinic. Tweets are mine; retweets not necessarily endorsements. He/him
Calgary, Alberta
Joined December 2018
- Tweets2K
- Following452
- Followers843
- Likes2.4K
Stephen Congly retweeted
In >11,000 ERCP patients, single-dose rectal NSAIDs were not associated with adverse renal outcomes, even among older adults and those with CKD. Read more at
🔗 ow.ly/5ljy50ZyajB
Stephen Congly retweeted
Our latest paper describing the pathophysiology of #IBS has just been published in @LancetGastroHep and you can access if for free using the link below:
authors.elsevier.com/c/1nS6A…
Stephen Congly retweeted
Rifaximin reduces the risk of readmissions for hepatic encephalopathy. One of the clearest cases where RCT-based effect sizes are reproducible in trials
journals.lww.com/hepcomm/ful…
@ArunJesudian @HepCommJournal
Stephen Congly retweeted
Brilliant editorial by @IanARowe: A “typical" (T2DM, HTA, BMI 34, DLP) at-risk MASH patient faces ~12% 10yr CV risk but only 1-3% liver-event risk. This gap shows management should prioritise weight loss and metabolic control before liver-directed therapy.journal-of-hepatology.eu/art…
Stephen Congly retweeted
🚨 AGA New Guideline Alert Link🚨
▶️ AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
👀 tinyurl.com/b43wwrfy
I’ll break down its FIVE recs over next 12 posts 🧵 👇
#AGA #GI #HBV #GITwitter #LiverTwitter
Hepatology and Gastroenterology @UCalgaryMed working together to treat dysphagia! How you might ask? Our recent @AGA_Gastro curbside consult with first author Mehul Gupta @UCalgaryIMRP explains how. @UCalgary gastrojournal.org/article/S0…
Thank you Andrew for sharing our work in @AmJGastro. Great effort from @UCalgaryIMRP resident @chunpengnie and colleagues in @CalDomMed and @UCalgaryMed to try and answer this important question for #HCC management #LiverTwitter
Tumor seeding is a dreaded complication of biopsy for HCC. But how common is it?
A systematic review in @AmJGastro reports a rate of tumor seeding of 0.62% with even lower rates in recent years, likely due to new techniques
Link: journals.lww.com/ajg/abstrac…
Stephen Congly retweeted
#PalliativeHepatology is HERE at @AASLDtweets #TLM2024! ⭐️⭐️⭐️ Please be sure to check out our Saturday sessions on Comprehensive Symptom Assessment/Management 📏💊(8A) and Serious Illness Communication Workshops 🗣️🗣️🗣️(11A and 2P), all in Ballroom 6E today! #Livertwitter
So excited for all the Palliative Hepatology content at AASLD The Liver Meeting 2024! We created a document with all the #PalliativeHepatology sessions at #AASLDTweets #TLM24 here: tinyurl.com/2nu78k3n
Stephen Congly retweeted
🎉 Hey Liver Lovers! 🎉 It’s time to nominate your favorite liver research superstar for the CASL-CLF Gold Medal Award! 🏆🩺 Think you know someone who’s liver-ly to win? Nominate them now!
Deadline: September 30, 2024. 👇
hepatology.ca/casl-awards/
Stephen Congly retweeted
Three hepatology masters receiving western hospitality. I see them ready for next year Stampede. @IanARowe @Jenn_Flemming @NDP1001
Stephen Congly retweeted
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement pubmed.ncbi.nlm.nih.gov/3885…
Stephen Congly retweeted
#Paperweek
Commentary @Gut_BMJ on the potential risk of #HEV transmission from 🐷-derived pancreatic enzyme medication.
Kudos @naturfuchs @KinastVolker
gut.bmj.com/content/early/20…
Stephen Congly retweeted
LDLT is growing in the US, but not all patients have equal access--financial toxicity presents a major barrier. Check out our article published in @amjtransplant this week where we discuss financial barriers and propose potential solutions:
amjtransplant.org/article/S1…
Stephen Congly retweeted
Come and check out our poster #1594 with some very interesting global variations in google trends of search terms #NAFLD #MAFLD and #MASLD
#DDW2024 @reguram_reshma @Stanford_GI
It has only taken me almost a year and a half but finally have a smartphrase for pickle brine for cramps in patients with cirrhosis journals.lww.com/ajg/fulltex… @ebtapper
1
13
1,465
Dr. Watt hits it right on the button. Next step is then to define appropriate target metrics beyond survival and graft survival (e.g. rate of biliary or vascular complications for instance)
To get better predictors of post transplant outcomes we need to agree on definitions of said outcomes. @_ILTS_ @AST_LICOP
2
369
A team effort identifying chronic HEV in lung transplant recipients with CF. Looking forward to continued collaboration to explore the possible connection of chronic hepatitis E with pancreatic enzymes #LiverTwitter @doucette_ked1
Our study in @Gut_BMJ was one of translational medicine and a clinical observation spanning the research lab with a full team effort. We look forward to further diving into this observation with more mechanistic studies. @sconglymd @CalDomMed
gut.bmj.com/content/early/20…
Stephen Congly retweeted
On May 9, CASL will join @ActionHepCanada, @canhepc, @CanHBVnetwork, and @LiverCanada for #CanHepDay24 in Ottawa.
Join CASL's executives and members to amplify our call for the federal and provincial governments. #HepCantWait
🔗bit.ly/3WBO3on


























